Page last updated: 2024-11-05

thiabendazole and Corneal Ulcer

thiabendazole has been researched along with Corneal Ulcer in 2 studies

Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate

Corneal Ulcer: Loss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection.

Research Excerpts

ExcerptRelevanceReference
"A 57-year-old man was treated for a corneal ulcer with a penetrating keratoplasty, followed by six weeks of a regimen of 4 to 8 mg of dexamethasone injected subconjunctivally daily."1.26Subconjunctival corticosteroid therapy complicated by hyperinfective strongyloidiasis. ( West, BC; Wilson, JP, 1980)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
West, BC1
Wilson, JP1
Wilson, LA1
Sexton, RR1
Ahearn, D1

Other Studies

2 other studies available for thiabendazole and Corneal Ulcer

ArticleYear
Subconjunctival corticosteroid therapy complicated by hyperinfective strongyloidiasis.
    American journal of ophthalmology, 1980, Volume: 89, Issue:6

    Topics: Conjunctiva; Corneal Ulcer; Dexamethasone; Humans; Immunity; Intestinal Diseases, Parasitic; Male; M

1980
Keratochromomycosis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1966, Volume: 76, Issue:6

    Topics: Chromoblastomycosis; Corneal Ulcer; Cryosurgery; Eye Injuries; Humans; Male; Middle Aged; Phialophor

1966